GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Additional Paid-In Capital

Acticor Biotech (XPAR:ALACT) Additional Paid-In Capital : €35.16 Mil(As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Additional Paid-In Capital?


Acticor Biotech's quarterly additional paid-in capital stayed the same from Jun. 2022 (€23.33 Mil) to Dec. 2022 (€23.33 Mil) but then increased from Dec. 2022 (€23.33 Mil) to Jun. 2023 (€35.16 Mil).

Acticor Biotech's annual additional paid-in capital increased from Dec. 2020 (€11.64 Mil) to Dec. 2021 (€23.32 Mil) and increased from Dec. 2021 (€23.32 Mil) to Dec. 2022 (€23.33 Mil).

Acticor Biotech Additional Paid-In Capital Historical Data

The historical data trend for Acticor Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Additional Paid-In Capital Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial 19.87 27.40 11.64 23.32 23.33

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only 13.02 23.32 23.33 23.33 35.16

Acticor Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Acticor Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Additional Paid-In Capital
Comparable Companies
XPAR:ALCLS XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ALVAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
7V7:Germany
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Website
https://www.acticor-biotech.com
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines